Another report supports the tumorigenic role of DRD2 in cancer stem cells, by demonstrating that DRD2 is a downstream target of the repressor element-1 silencing transcription factor (REST) that drives tumorigenesis in glioblastoma stem-like cells by regulating invasion and apoptosis (48). The gene discussed is REST; the disease is cancer.